Douglas A. Jabs mostly deals with Surgery, Eye disease, Internal medicine, Uveitis and Retrospective cohort study. The Surgery study combines topics in areas such as Retinitis, Cohort study and Disease. Douglas A. Jabs combines subjects such as Retinopathy and Acquired immunodeficiency syndrome with his study of Retinitis.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Scleritis, Cytomegalovirus retinitis and Immunology. The subject of his Uveitis research is within the realm of Ophthalmology. His research in the fields of Visual acuity, Macular edema and Epiretinal membrane overlaps with other disciplines such as Visual impairment.
Douglas A. Jabs spends much of his time researching Surgery, Cytomegalovirus retinitis, Retinitis, Ophthalmology and Uveitis. Douglas A. Jabs works mostly in the field of Surgery, limiting it down to concerns involving Internal medicine and, occasionally, Gastroenterology. His Cytomegalovirus retinitis research includes elements of Acquired immunodeficiency syndrome and Pediatrics.
His Retinitis study combines topics from a wide range of disciplines, such as Prospective cohort study, Betaherpesvirinae and Viral load. His Uveitis research is multidisciplinary, incorporating elements of Dermatology, Fluocinolone acetonide and Disease. His biological study spans a wide range of topics, including Immunopathology and Pathology.
His primary scientific interests are in Confidence interval, Training set, Uveitis, Ophthalmology and Internal medicine. His research in Training set intersects with topics in Anterior uveitis, Intermediate uveitis, Fluorescein angiography and Pediatrics. His Uveitis research is multidisciplinary, incorporating perspectives in Choroiditis, Optometry, Visual acuity and Disease.
His work on Retinal as part of general Ophthalmology study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Internal medicine study frequently draws connections to adjacent fields such as Acquired immunodeficiency syndrome. His work deals with themes such as Longitudinal study and Cytomegalovirus retinitis, which intersect with Prospective cohort study.
The scientist’s investigation covers issues in Uveitis, Internal medicine, Incidence, Proportional hazards model and Prospective cohort study. His Uveitis research is included under the broader classification of Ophthalmology. All of his Internal medicine and Retrospective cohort study and Immunosuppression investigations are sub-components of the entire Internal medicine study.
In his research, Scleritis and Granulomatosis with polyangiitis is intimately related to Rheumatoid arthritis, which falls under the overarching field of Incidence. Douglas A. Jabs has included themes like Severity of illness and Acquired immunodeficiency syndrome in his Prospective cohort study study. Douglas A. Jabs interconnects Lesion, Retinitis, Cytomegalovirus retinitis, Immunodeficiency and Cross-sectional study in the investigation of issues within Acquired immunodeficiency syndrome.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.
Douglas A Jabs;Robert B Nussenblatt;James T Rosenbaum.
American Journal of Ophthalmology (2005)
Paraneoplastic Pemphigus: An Autoimmune Mucocutaneous Disease Associated with Neoplasia
GJ Anhalt;SC Kim;JR Stanley;NJ Korman.
The New England Journal of Medicine (1990)
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
Douglas A. Jabs;James T. Rosenbaum;C.Stephen Foster;Gary N. Holland.
American Journal of Ophthalmology (2000)
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002
Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston.
Annals of Internal Medicine (2002)
Thalidomide for the treatment of chronic graft-versus-host disease.
G B Vogelsang;E R Farmer;A D Hess;V Altamonte.
The New England Journal of Medicine (1992)
Cytomegalovirus retinitis and acquired immunodeficiency syndrome.
Douglas A. Jabs;Cheryl Enger;John G. Bartlett.
Archives of Ophthalmology (1989)
Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
Peter W. Hunt;Elizabeth Sinclair;Benigno Rodriguez;Carey Shive.
The Journal of Infectious Diseases (2014)
Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
Grace Levy-Clarke;Douglas A. Jabs;Russell W. Read;James T. Rosenbaum.
Ocular Involvement in Chronic Sarcoidosis
Douglas A. Jabs;Carol J. Johns.
American Journal of Ophthalmology (1986)
Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.
Justine R. Smith;Ralph D. Levinson;Gary N. Holland;Douglas A. Jabs.
Arthritis & Rheumatism (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: